Morgan Stanley
CURE icon

Morgan Stanley’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Morgan Stanley’s Portfolio CURE Stock Details CURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$152 Buy
+1
New +$109 ﹤0.01% 7733
2025
Q4 		– Sell
-1
Closed -$123 – 8260
2025
Q3 		$123 Sell
1
-455
-100% -$35.4K ﹤0.01% 7650
2025
Q2 		$36K Buy
456
+244
+115% +$19.7K ﹤0.01% 6469
2025
Q1 		$22.6K Sell
212
-709
-77% -$75.4K ﹤0.01% 6529
2024
Q4 		$85K Buy
921
+334
+57% +$37.6K ﹤0.01% 6118
2024
Q3 		$78.2K Buy
587
+583
+14,575% +$75.1K ﹤0.01% 6085
2024
Q2 		$509 Buy
4
+3
+300% +$338 ﹤0.01% 7228
2024
Q1 		$128 Sell
1
-1,019
-100% -$118K ﹤0.01% 7350
2023
Q4 		$104K Buy
1,020
+867
+567% +$77.7K ﹤0.01% 6148
2023
Q3 		$13.6K Sell
153
-278
-65% -$27.3K ﹤0.01% 6611
2023
Q2 		$43.1K Sell
431
-72
-14% -$7.16K ﹤0.01% 6266
2023
Q1 		$48.3K Buy
503
+343
+214% +$34.4K ﹤0.01% 6301
2022
Q4 		$18.4K Buy
160
+9
+6% +$973 ﹤0.01% 6726
2022
Q3 		$13K Sell
151
-236
-61% -$24.3K ﹤0.01% 6976
2022
Q2 		$40K Buy
387
+68
+21% +$7.67K ﹤0.01% 6703
2022
Q1 		$42K Sell
319
-1,493
-82% -$178K ﹤0.01% 6786
2021
Q4 		$263K Sell
1,812
-112
-6% -$13.6K ﹤0.01% 5913
2021
Q3 		$207K Buy
1,924
+1,351
+236% +$162K ﹤0.01% 5979
2021
Q2 		$60K Buy
573
+383
+202% +$36.8K ﹤0.01% 6594
2021
Q1 		$16K Sell
190
-188
-50% -$15.2K ﹤0.01% 6794
2020
Q4 		$29K Sell
378
-772
-67% -$53.1K ﹤0.01% 6333
2020
Q3 		$72K Buy
1,150
+604
+111% +$37.9K ﹤0.01% 5571
2020
Q2 		$30K Buy
546
+100
+22% +$5.31K ﹤0.01% 5871
2020
Q1 		$18K Sell
446
-2,362
-84% -$149K ﹤0.01% 5843
2019
Q4 		$207K Buy
2,808
+1,489
+113% +$91K ﹤0.01% 5399
2019
Q3 		$67K Buy
1,319
+577
+78% +$30.6K ﹤0.01% 5586
2019
Q2 		$42K Sell
742
-2,112
-74% -$109K ﹤0.01% 5676
2019
Q1 		$159K Buy
2,854
+1,740
+156% +$92.5K ﹤0.01% 5178
2018
Q4 		$53K Sell
1,114
-3,309
-75% -$186K ﹤0.01% 5747
2018
Q3 		$294K Buy
4,423
+3,677
+493% +$210K ﹤0.01% 5276
2018
Q2 		$34K Buy
746
+685
+1,123% +$30.6K ﹤0.01% 6007
2018
Q1 		$3K Sell
61
-3,471
-98% -$174K ﹤0.01% 6449
2017
Q4 		$165K Buy
+3,532
New +$164K ﹤0.01% 5477
2017
Q3 		– Sell
-3,870
Closed -$161K – 6542
2017
Q2 		$161K Sell
3,870
-1,271
-25% -$47K ﹤0.01% 5445
2017
Q1 		$177K Buy
5,141
+2,979
+138% +$96.8K ﹤0.01% 5377
2016
Q4 		$60K Sell
2,162
-340
-14% -$9.59K ﹤0.01% 5701
2016
Q3 		$79K Sell
2,502
-661
-21% -$22.5K ﹤0.01% 5403
2016
Q2 		$100K Buy
3,163
+2,215
+234% +$66.8K ﹤0.01% 5239
2016
Q1 		$26K Sell
948
-1,303
-58% -$34.3K ﹤0.01% 5840
2015
Q4 		$75K Buy
2,251
+1,815
+416% +$57.4K ﹤0.01% 5557
2015
Q3 		$12K Sell
436
-4,573
-91% -$168K ﹤0.01% 6193
2015
Q2 		$197K Buy
5,009
+2,889
+136% +$100K ﹤0.01% 5239
2015
Q1 		$62K Buy
+2,120
New +$59.2K ﹤0.01% 5714

Other funds holding CURE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
OBWG
Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return
PWPS
Pinnacle Wealth Planning Services Mansfield, Ohio $968M AUM 19.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley's CURE Position: Q1 2026 in Review

Morgan Stanley opened a new position in Direxion Daily Healthcare Bull 3X ETF (CURE) in Q1 2026: 1 share worth $152. The stake represents ﹤0.01% of the portfolio and ranks #7733 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in CURE as recently as Q3 2025.

Morgan Stanley first reported a position in CURE in Q1 2015 and has held it in 43 quarters since. The position peaked at $294K in Q3 2018. 15 funds tracked by Wall St. Rank hold CURE as of Q1 2026.

  • Morgan Stanley held 1 share of Direxion Daily Healthcare Bull 3X ETF worth $152 as of Q1 2026.
  • Direxion Daily Healthcare Bull 3X ETF was a new Morgan Stanley position in Q1 2026.
  • Direxion Daily Healthcare Bull 3X ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7733 holding.
  • Morgan Stanley first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2015 and has held it in 43 quarters since.
  • Morgan Stanley's Direxion Daily Healthcare Bull 3X ETF position peaked at $294K in Q3 2018.
  • 15 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.